Medirox provides reagents for the routine and speciality coagulation diagnostics . Medirox has become a well-known international supplier both to distributors and OEM partners world-wide. The products are CE marked and produced under ISO 13485:2016 regulations.
Order & Production
The manufacturing takes place at our company headquarter located at Studsvik’s outskirts of Nyköping. Here we handle production, administration, logistics, warehousing and quality control.
The production site is located in Studsvik, near the city of Nyköping, Sweden, approximately one-hour south of Stockholm. The production site is equipped with our own quality control laboratory, cold storage, biochemical production, lyophilising units etc. At the production site we also have other functions such as order, logistics, warehousing and administration.
Sales & Marketing
As a customer-driven organisation, our highly specialised staff at the marketing department works hard to support our customers across the globe.
Medirox Sales & Marketing office is located in Stockholm, Sweden. Here we have a dedicated team that is commited to support our partners and distributors. Medirox is actively expanding its network of distributors who can bring our high quality coagulation reagents to laboratories around the world.
Research & Development
Medirox’s R&D department is located at Medicine and Health Sciences, Linköping University. Here, we develop reagents, plasma control material and plasma calibrators for coagulation diagnostics.
Medirox R&D department is located in Linköping, Sweden. The department is situated within the University Hospital and we have a close collaboration with the University Hospital and their laboratory and their clinical experts within haemostasis. Our R&D team is continuously developing new reagents that are requested in the market and therefore we have several new reagents in the pipeline.
The Medirox team consists of experienced managers, scientists, technicians and regulatory resources who are ready to support you.
Medirox was formed in 1998 from a merger of three companies; a research company called Global Haemostasis Institute and two major Scandinavian distributors within haemostasis – IL Scandinavia AB and BioMed AB. The company has therefore a longer history than 20 years in the field and has a strong research focus and a solid knowledge on the haemostasis field.